TWFG TWFG
- Market cap
- $1.5B
- PE
- 47.1×
- 1y median 45.8×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 5.2×
- EV/EBIT
- 31.1×
- Revenue, 12 months
- $294.7M
- +35% on a year ago
- Net margin
- n/m
- one or more of the four quarters through 2026-06-30 missing
- Free cash flow yield
- 3.9%
TWFG trades at 47.1× trailing earnings, near its ten-year median. Revenue was $294.7M over the last twelve months, up 35% on a year earlier.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $47.7M | $39.1M | $46.1M+16% | $53M+17% | $52.9M+11% | $51.7M+32% | $53.8M+17% | $60.3M+14% | $64.1M+21% | $70.3M+36% | $72.8M+35% | $87.5M+45% | |
| $7.9M | $4.8M | $7.3M+34% | $7.5M+4% | $6M−25% | $7.1M+49% | $5.7M−22% | $7.4M−2% | $9M+51% | $14.9M+108% | $12.4M+116% | $17.6M+139% | |
| Interest expense | $295K | $450K | $842K+891% | $872K+404% | $411K+39% | $98K−78% | $83K−90% | $68K−92% | $70K−83% | $66K−33% | $62K−25% | $57K−16% |
| Pre-tax income | $7.6M | $5.2M | $6.6M | $6.9M | $7.3M−4% | $9.2M+77% | $7.5M+13% | $9.6M+39% | $10.6M+45% | $16.7M+82% | $14.2M+89% | $18.3M+90% |
| $0 | $0 | $0 | $0 | $437K | $1.1M | $656K | $620K | $977K+124% | $1M−3% | $1.1M+73% | $1M+66% | |
| Net income | $7.6M | −$20.9M | $0 | $0 | $1.2M−85% | $1.6M | $1.3M | $2M | $1.7M+49% | n/a | $1.8M+31% | $2.4M+21% |
| n/a | n/a | $10.05+2% | $10.49−6% | $0.08 | $0.10 | $0.09−99% | $0.13−99% | $0.11+38% | $0.19+90% | $0.12+33% | $0.18+39% | |
| n/a | n/a | 659.4K+4% | 659.4K+4% | 14.9M | 15.3M | 15.1M+2183% | 56.3M+8434% | 15.1M+1% | 15.1M−1% | 14.9M−1% | 13.1M−77% |
Revenue: Q1 FY23: 6 months less the 3 months printed beside them.
Operating income: Q1 FY23: 6 months less the 3 months printed beside them.
Interest expense: Q1 FY23 and Q1 FY24: 6 months less the 3 months printed beside them.
Net income: Q1 FY23: 6 months less the 3 months printed beside them.
EPS, diluted: 4 periods, Q1 FY23 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY23 and Q1 FY24: share-days: the 6-month average less the second quarter's. Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Insurance - Brokers nearest TWFG's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| TWFGTWFG | $1.5B | 47.1× | 45.8× | 5.2× | +35% | n/m | |
| GSHDGoosehead Insurance | $1.7B | 39.8× | 175× | 4.3× | +18% | 8.8% | |
| CRD-ACrawford | $603.7M | 32.7× | 15.6× | 0.5× | −4% | 1.8% | |
| NPNeptune Insurance | $3.9B | 91.7× | 126× | 19.9× | +34% | 22.7% | |
| CRVLCorvel | $4.2B | 37.3× | 38.1× | 4.3× | +7% | 11.7% | |
| HGTYHagerty | $5.4B | 260× | 50.9× | 3.7× | +8% | 1.8% | |
| ACTEnact | $6.6B | 10.1× | 7.8× | 5.3× | +2% | 54.5% | |
| RYANRyan Specialty | $11.2B | 60.7× | 92.3× | 3.5× | +14% | 3.1% | |
| ERIEErie Indemnity | $13.3B | 23.0× | 31.6× | 3.2× | +4% | 14.0% | |
| Peer median | $4.8B | 38.5× | 44.5× | 4.0× | +8% | 10.2% |
Investors who own it
Investors we follow who held TWFG at the end of Jun 30, 2026, from their 13F filings.
- François RochonGiverny Capital0.5% of portfolioadded
- Ron BaronBaron Capital0.0% of portfoliotrimmed
More on TWFG
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 19Insurance brokers with the fastest revenue growth
- #2of 11Insurance brokers with the fastest earnings growth
- #10of 13Insurance brokers with the highest free cash flow yield
Its groups
About
- Industry
- Insurance - Brokers
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .